mesoblast

Latest news and analysis on mesoblast

Equities

Game changing potential for loss-making Mesoblast

Melbourne-based biotech Mesoblast will achieve a world-first that could open up its drug pipeline to a massive market if it wins US Food and Drug Administration...
Glenn Freeman
Livewire Markets

A biotech that's been misunderstood

MSB
Livewire Exclusive
Livewire Markets

Mesoblast (ASX: MSB) - Why I expect Team Silviu can make a strong comeback

Stuart Roberts
Stuart Roberts
Pitt Street Research and NDF Research

Legislation just passed in Japan could accelerate Mesoblast's (MSB) entry into the largest market outside of the US

James Marlay
Livewire Markets
4
The 10th annual Livewire Live 2026

One room. One day. The minds that move markets.

22 September 2026 Art Gallery of NSW, Sydney

Register Now